Overview

Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to examine the effect of pramlintide given pre-meal and insulin given just after a meal vs. standard therapy of pre-meal insulin on post-prandial glucose excursions. The secondary objective is to examine the effect of pramlintide and insulin on glucagon suppression in type 1 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Baylor College of Medicine
Montefiore Medical Center
Collaborator:
Amylin Pharmaceuticals, LLC.
Treatments:
Insulin
Insulin, Globin Zinc
Islet Amyloid Polypeptide
Pramlintide